MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines.

Saved in:
Bibliographic Details
Title: MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines.
Authors: Almhanna K; H. Lee Moffitt Cancer Center & Research Institute; Tampa, FL USA., Cubitt CL, Zhang S, Kazim S, Husain K, Sullivan D, Sebti S, Malafa M
Source: Cancer biology & therapy [Cancer Biol Ther] 2013 Oct 01; Vol. 14 (10), pp. 932-6. Date of Electronic Publication: 2013 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1555-8576
DOI:10.4161/cbt.25939